Trial Profile
Efficacy and safety of Mirabegron for treatment OAB in the postmenopausal female patients -Evaluation using Pressure Flow Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Oct 2015 New trial record